Opportunities for Aligning Prescription Drug Affordability Boards and Cost-Growth Benchmarks
NASHP
NOVEMBER 15, 2021
In states such as Massachusetts, there is also a threat of a targeted performance improvement plan for entities determined to be cost drivers. The benchmark is generally enforced by noting stakeholders that are responsible for high costs during public meetings and in public reports.
Let's personalize your content